Exagen Inc. (XGN) on GreekSoup https://greeksoup.ai/stocks/us/xgn/ Every dated entry in the public record on Exagen Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Exagen Inc.: Chernett Jorey (10% owner) bought 14,000 shares at $7.46 on 19 October 2026, $104,440https://greeksoup.ai/stocks/us/xgn/insiders/us:XGN:insider:2026-10-20:2d30be2791Tue, 20 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Exagen Inc.: Aballi John (President and CEO) sold 34,294 shares at $7.87 on 16 October 2026, $269,791https://greeksoup.ai/stocks/us/xgn/insiders/us:XGN:insider:2026-10-19:f84064296eMon, 19 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Exagen Inc.: short interest 673,850 shares at the 15 October 2026 settlement, 1.82 days to coverhttps://greeksoup.ai/stocks/us/xgn/short-interest/us:XGN:short-interest:2026-10-15:ffb9af057eThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Exagen Inc.: short interest 704,634 shares at the 30 September 2026 settlement, 2.46 days to coverhttps://greeksoup.ai/stocks/us/xgn/short-interest/us:XGN:short-interest:2026-09-30:69a4e48746Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Exagen Inc.: short interest 800,344 shares at the 15 September 2026 settlement, 3.59 days to coverhttps://greeksoup.ai/stocks/us/xgn/short-interest/us:XGN:short-interest:2026-09-15:c6037cf7feTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Exagen Inc.: Black Jeffrey G. (Chief Financial Officer) sold 20,614 shares at $7.22 on 1 September 2026, $148,782https://greeksoup.ai/stocks/us/xgn/insiders/us:XGN:insider:2026-09-02:c099212742Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Exagen Inc.: short interest 864,038 shares at the 31 August 2026 settlement, 2.55 days to coverhttps://greeksoup.ai/stocks/us/xgn/short-interest/us:XGN:short-interest:2026-08-31:b1c1906f1cMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Exagen Inc.: short interest 940,432 shares at the 14 August 2026 settlement, 1.50 days to coverhttps://greeksoup.ai/stocks/us/xgn/short-interest/us:XGN:short-interest:2026-08-14:aa9d133189Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Exagen Inc. Q2 FY2026 results: revenue $20 million, net income -$3 millionhttps://greeksoup.ai/stocks/us/xgn/results/fy2026-q2/us:XGN:result:2026-08-04:0569c5c76aTue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Exagen Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/xgn/filings/us:XGN:filing:2026-08-04:3879d23c8aTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Exagen Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/xgn/filings/us:XGN:filing:2026-08-04:299290869cTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>